DK173628B1 - Farmaceutiske præparater indeholdende mikroniserede EBSELEN-krystaller - Google Patents

Farmaceutiske præparater indeholdende mikroniserede EBSELEN-krystaller Download PDF

Info

Publication number
DK173628B1
DK173628B1 DK198803333A DK333388A DK173628B1 DK 173628 B1 DK173628 B1 DK 173628B1 DK 198803333 A DK198803333 A DK 198803333A DK 333388 A DK333388 A DK 333388A DK 173628 B1 DK173628 B1 DK 173628B1
Authority
DK
Denmark
Prior art keywords
ebselen
pharmaceutical compositions
crystals
solid pharmaceutical
micronized
Prior art date
Application number
DK198803333A
Other languages
Danish (da)
English (en)
Other versions
DK333388D0 (da
DK333388A (da
Inventor
Axel Roemer
Juergen Seidel
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of DK333388D0 publication Critical patent/DK333388D0/da
Publication of DK333388A publication Critical patent/DK333388A/da
Application granted granted Critical
Publication of DK173628B1 publication Critical patent/DK173628B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D293/12—Selenazoles; Hydrogenated selenazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK198803333A 1987-06-20 1988-06-17 Farmaceutiske præparater indeholdende mikroniserede EBSELEN-krystaller DK173628B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3720493 1987-06-20
DE19873720493 DE3720493A1 (de) 1987-06-20 1987-06-20 Arzneizubereitungen mit mikronisierten ebselen-kristallen

Publications (3)

Publication Number Publication Date
DK333388D0 DK333388D0 (da) 1988-06-17
DK333388A DK333388A (da) 1988-12-21
DK173628B1 true DK173628B1 (da) 2001-05-07

Family

ID=6330016

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198803333A DK173628B1 (da) 1987-06-20 1988-06-17 Farmaceutiske præparater indeholdende mikroniserede EBSELEN-krystaller

Country Status (25)

Country Link
US (1) US5021242A (uk)
EP (1) EP0296389B1 (uk)
JP (1) JPH0713016B2 (uk)
KR (1) KR970005322B1 (uk)
AT (1) ATE69165T1 (uk)
AU (1) AU603454B2 (uk)
CA (1) CA1310906C (uk)
DD (1) DD271056A5 (uk)
DE (2) DE3720493A1 (uk)
DK (1) DK173628B1 (uk)
ES (1) ES2041736T3 (uk)
FI (1) FI88256C (uk)
GE (1) GEP19960342B (uk)
GR (1) GR3003084T3 (uk)
HU (1) HU200096B (uk)
IE (1) IE63512B1 (uk)
LT (1) LT3669B (uk)
LV (1) LV10381B (uk)
MX (1) MX169170B (uk)
NO (1) NO175133C (uk)
NZ (1) NZ225066A (uk)
PT (1) PT87767B (uk)
RU (1) RU1834657C (uk)
UA (1) UA12648A (uk)
ZA (1) ZA884025B (uk)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368864A (en) * 1988-11-25 1994-11-29 Henning Berlin Gmbh Chemie- Und Pharmawerk Formulation of oxypurinol and/or its alkali and alkaline earth salts
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP2553434B2 (ja) * 1992-04-28 1996-11-13 第一製薬株式会社 粒状製剤
ES2145065T3 (es) * 1993-10-27 2000-07-01 Daiichi Seiyaku Co Preparacion granular.
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
CN1090935C (zh) * 1995-02-28 2002-09-18 阿温蒂斯药物公司 哌啶子基烷醇化合物的药物组合物
NZ501248A (en) * 1997-08-26 2001-06-29 Aventis Pharma Inc Pharmaceutical composition for combination of piperidinoalkanol-decongestant
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
AU3457300A (en) 1999-03-31 2000-10-16 Daiichi Pharmaceutical Co., Ltd. Substrates for thioredoxin reductase
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
EP1603867A2 (en) * 2003-02-24 2005-12-14 Mallinckrodt Inc. Process for preparing benzhydrylthioacetamide
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
WO2008148064A1 (en) * 2007-05-23 2008-12-04 Sunesis Pharmaceuticals, Inc. Weight loss treatment
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
TW201613888A (en) 2014-09-26 2016-04-16 Helsinn Healthcare Sa Crystalline forms of an NK-1 antagonist
WO2022167778A1 (en) * 2021-02-02 2022-08-11 Haiku Therapeutics Ltd Ebselen as adenosine receptor modulator
WO2023240092A1 (en) * 2022-06-06 2023-12-14 Sound Pharmaceuticals Inc. Ebselen containing oral dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3407511A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen

Also Published As

Publication number Publication date
GEP19960342B (en) 1996-02-20
KR970005322B1 (ko) 1997-04-15
PT87767B (pt) 1992-10-30
ZA884025B (en) 1988-12-20
FI88256B (fi) 1993-01-15
MX169170B (es) 1993-06-23
CA1310906C (en) 1992-12-01
EP0296389A1 (de) 1988-12-28
EP0296389B1 (de) 1991-11-06
AU603454B2 (en) 1990-11-15
NO882615D0 (no) 1988-06-14
ATE69165T1 (de) 1991-11-15
LT3669B (en) 1996-01-25
NZ225066A (en) 1990-07-26
AU1811688A (en) 1988-12-22
LV10381A (lv) 1995-02-20
IE881628L (en) 1988-12-20
DK333388D0 (da) 1988-06-17
RU1834657C (ru) 1993-08-15
US5021242A (en) 1991-06-04
DK333388A (da) 1988-12-21
PT87767A (pt) 1989-05-31
FI882912A0 (fi) 1988-06-17
NO882615L (no) 1988-12-21
JPH01100125A (ja) 1989-04-18
KR890000084A (ko) 1989-03-11
DE3720493A1 (de) 1989-01-26
DD271056A5 (de) 1989-08-23
LV10381B (en) 1995-06-20
JPH0713016B2 (ja) 1995-02-15
LTIP903A (en) 1995-03-27
NO175133B (no) 1994-05-30
HUT50037A (en) 1989-12-28
NO175133C (no) 1994-09-07
GR3003084T3 (en) 1993-02-17
DE3866033D1 (de) 1991-12-12
FI88256C (fi) 1993-04-26
HU200096B (en) 1990-04-28
UA12648A (uk) 1997-02-28
FI882912A (fi) 1988-12-21
ES2041736T3 (es) 1996-07-16
IE63512B1 (en) 1995-05-03

Similar Documents

Publication Publication Date Title
DK173628B1 (da) Farmaceutiske præparater indeholdende mikroniserede EBSELEN-krystaller
US4877620A (en) Ibuprofen-containing medicament
RU2221563C2 (ru) Фармацевтическая композиция для лечения болезни паркинсона и синдромов паркинсона, способ ее получения, способ лечения болезни паркинсона и синдромов паркинсона
CN102186350A (zh) 使用(r)-普拉克索的组合物与方法
US5792476A (en) Sustained release glucocorticoid pharmaceutical composition
AU722304B2 (en) Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application
CA2207437A1 (en) Use of incense in the treatment of alzheimer's disease
IE58612B1 (en) Combination product composed of pyrimido-pyrimidines and o-acetylsalicyclic acid or its pharmacologically tolerated salts and its use
JP2557303B2 (ja) 抗腫瘍効果増強剤及び抗腫瘍剤
AU656443B2 (en) Pharmaceutical composition for the improvement of dysuria
US20220009889A1 (en) Polymorphic form of meisoindigo and modified formulation of meisoindigo
JPS5925765B2 (ja) 消化性潰瘍治療剤
US20240285532A1 (en) A plurality of tasquinimod particles and use thereof
EP0811379A1 (en) Therapeutic agent for dermatosis
KR19990082277A (ko) 경구투여용 5 알파-환원효소 저해제제, 그의 제조방법 및 그의사용
JPH0374330A (ja) 脱髄疾患治療剤
CN101062047B (zh) 一种含有异甘草酸和苦参素的组合物及其用途
JPS62270529A (ja) 抗アレルギ−剤
JPH0228113A (ja) 高尿酸血症改善・治療剤
JPH03275698A (ja) グリチルレチン酸代謝物およびグリチルレチン酸代謝物を有効成分とする３α―ヒドロキシステロイドデヒドロゲナーゼ阻害剤
JPS59184124A (ja) 腎不全、糖尿病及び糖尿病性腎症におけるエネルギー代謝改善剤
EP0687468A2 (en) Pharmaceutical composition for suppressing infiltration of eosinophils
JPH08113538A (ja) デメチルゼイラストラールの用途

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired